Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion type Assertion NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_head.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion description "[In this global meta-analysis, reduced CYP2C19 function appears to expose clopidogrel-treated patients to excess cardiovascular risk and mortality. Conflicting results among studies may be explained by differences in types and/or levels of risk of patients]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_provenance.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion evidence source_evidence_literature NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_provenance.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion SIO_000772 20620727 NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_provenance.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion wasDerivedFrom gad-20150221 NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_provenance.
- NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_assertion wasGeneratedBy ECO_0000203 NP180970.RAlbTB5Ka-Qu3PzdFnwChn37vtv9nAq5C1-p1VwJ7cOM4130_provenance.